Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLAIN motif family member 2 (SLAIN2) is a cytoplasmic protein that binds to the plus end of microtubules and plays a critical role in regulating microtubule dynamics and organization, particularly by promoting microtubule nucleation and elongation[1][2][3]. SLAIN2 acts as a key component of the microtubule plus-end tracking protein (+TIP) network; it interacts directly with end-binding proteins (EBs), cytoplasmic linker proteins (CLIPs), CLIP-associated proteins (CLASPs), and ch-TOG, the mammalian homolog of the microtubule polymerase XMAP215[2]. Through these interactions, SLAIN2 enhances ch-TOG accumulation at growing microtubule ends, thereby stimulating polymerization specifically in interphase. SLAIN2 is highly phosphorylated during mitosis, which abrogates its interaction with other +TIPs and its localization at microtubule plus ends, allowing for cell cycle–specific modulation of microtubule dynamics[2]. SLAIN2 is not classified as a receptor, enzyme, transporter, or traditional therapeutic target, but is a structurally and functionally important scaffolding protein within the cytoskeleton.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLAIN motif family member 2 (SLAIN2).